Atea Pharmaceuticals Inc header image

Atea Pharmaceuticals Inc

AVIR

Equity

ISIN null / Valor 57645639

NASDAQ (2026-04-30)
USD 5.51+1.47%

Atea Pharmaceuticals Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing innovative oral antiviral therapies to meet unmet medical needs. Specializing in novel antiviral treatments, Atea leverages its expertise in drug discovery and development to create effective oral medications targeting a range of viral infections. The company’s pipeline includes several promising candidates aimed at addressing gaps in current treatment options, positioning Atea as a significant contributor to advancing antiviral therapies in the pharmaceutical industry.

Summarized from source with an LLMView SourceSector:

Latest Results ():

Summarized from source with an LLMView Source

Key figures

86.8%1Y
68.5%3Y
-77.7%5Y

Performance

48.7%1Y
50.5%3Y
76.5%5Y

Volatility

Market cap

439 M

Market cap (USD)

Daily traded volume (Shares)

203,108

Daily traded volume (Shares)

1 day high/low

3.38 / 3.28

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00